Gaithersburg, Maryland, United States The main department of described VC is located in the Gaithersburg. The venture was found in North America in United States.
Among the most popular portfolio startups of the fund, we may highlight Cellerant Therapeutics, TransMedics, ARYx Therapeutics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Therapeutics, Medical Device. The fund has exact preference in a number of founders of portfolio startups.
The typical case for the fund is to invest in rounds with 8-9 participants. Despite the Novel Bioventures, startups are often financed by OrbiMed, Yozma Group, MPM Capital. The meaningful sponsors for the fund in investment in the same round are OrbiMed, MPM Capital, Yozma Group. In the next rounds fund is usually obtained by MPM Capital, VantagePoint Capital Partners, Sherbrooke Capital.
Opposing the other organizations, this Novel Bioventures works on 46 percentage points more the average amount of lead investments. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2005. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AVN Business Solutions Pvt. Ltd. | Aurangabad, India, Maharashtra |
| BT Growth Capital | - |
| Code for America | California, San Francisco, United States |
| Effective Investments | Kyiv, Ukraine, Київська міська громада |
| Engel Ventures | California, Santa Barbara, United States |
| Eteron VC | Greater Poland Voivodeship, Poland, Poznań |
| Game Tech Ventures | England, London, United Kingdom |
| Kokopelli Capital | - |
| L Capital | - |
| LONGHOO | China, Jiangsu, Nanjing |
| Martin Companies | Kilgore, Texas, United States |
| Meiko Network Japan | Chiyoda, Japan |
| Morgan Creek Capital Management | Chapel Hill, North Carolina, United States |
| Nuclio Venture Builder | Barcelona, Catalonia, Spain |
| Pulau Manukan Ventures | - |
| RPD Innovations | Ar Riyad, Riyadh, Saudi Arabia |
| Sime Darby | Kuala Lumpur, Malaysia |
| University of Minnesota Discovery Capital Investment | - |
| Xingyu Touzi | China, Jiangsu, Jintan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cellerant Therapeutics | $16M | 11 May 2005 | California, United States | ||
Predix Pharmaceuticals | $43M | 27 Jan 2005 | Boston, Massachusetts, United States | ||
TransMedics | $27M | 27 Jan 2004 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cellerant Therapeutics | $16M | 11 May 2005 | California, United States | ||
Predix Pharmaceuticals | $43M | 27 Jan 2005 | Boston, Massachusetts, United States | ||
TransMedics | $27M | 27 Jan 2004 | Massachusetts, United States |
